Evidence map›Paper›PMID 37373396›Full record

ArticleInternational journal of molecular sciences2023

Open-Spaced Ridged Hydrogel Scaffolds Containing TiO

Ahad M Siddiqui, Frederic Thiele, Rachel N Stewart, Simone Rangnick, Georgina J Weiss, Bingkun K Chen, Jodi L Silvernail, Tammy Strickland, Jarred J Nesbitt, Kelly Lim and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 4 countries.

Ahad M SiddiquiDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3334-1728
Frederic ThieleDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Rachel N StewartDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-7293-0205
Simone RangnickDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Georgina J WeissDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Bingkun K ChenDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Jodi L SilvernailDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Tammy StricklandDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-4185-446X
Jarred J NesbittDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Kelly LimDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Jean E SchwarzbauerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0003-1012-7593
Jeffrey SchwartzDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Michael J YaszemskiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Anthony J WindebankDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Nicolas N MadiganDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3652-7456
Mayo Clinic · USPrinceton University · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
Fibronectin-dependent mechanisms governing the assembly of a definitive extracellular matrixR01AR073236 · NIAMS · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 2018 to 2022
$1.7M
NCATS NIH HHS TL1 TR002380NCATS NIH HHS UL1 TR002377NIAMS NIH HHS R01 AR073236NIAMS NIH HHS R01AR073236
6 · The paper itself

Abstract

The spinal cord has a poor ability to regenerate after an injury, which may be due to cell loss, cyst formation, inflammation, and scarring. A promising approach to treating a spinal cord injury (SCI) is the use of biomaterials. We have developed a novel hydrogel scaffold fabricated from oligo(poly(ethylene glycol) fumarate) (OPF) as a 0.08 mm thick sheet containing polymer ridges and a cell-attractive surface on the other side. When the cells are cultured on OPF via chemical patterning, the cells attach, align, and deposit ECM along the direction of the pattern. Animals implanted with the rolled scaffold sheets had greater hindlimb recovery compared to that of the multichannel scaffold control, which is likely due to the greater number of axons growing across it. The immune cell number (microglia or hemopoietic cells: 50-120 cells/mm

Indexed as

OrganophosphonatesSpinal Cord InjuriesAnimalsAxonsCicatrixFumaratesHydrogelsNerve RegenerationPolyethylene GlycolsRatsRats, Sprague-DawleySpinal CordTissue ScaffoldsTitaniumFumaratesHydrogelsOrganophosphonatespoly(ethylene glycol fumarate)Polyethylene GlycolsTitaniumtitanium dioxideaxon regenerationbiomaterialsimmune cellsmachine learningmesenchymal stromal cells (MSCs)oligo(poly(ethylene glycol)) fumaratescarringSchwann cellsspinal cord injurytitanium dioxide

Identifiers

PMID37373396
PMCPMC10299197
OpenAlexW4380989515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.